Mital Jhaveri/LinkedIn
Apr 23, 2026, 14:46
Mital Jhaveri: Anticoagulant Approval and Uptake Timeline
Mital Jhaveri, Heart Failure Pharmacist at NYC HHC Queens Hospital Center, shared a post on LinkedIn.
“When presenting on anticoagulation recently, I was asked a thought-provoking question: why is anticoagulant use increasing?
The answer goes beyond simply ‘more prescriptions.’
It boils down to two main factors: ease of use and a growing need.
Here are a few key reasons:
- Safer, easier medications: Newer anticoagulants are more predictable, require less monitoring, and have fewer interactions.
- Wider clinical use: Anticoagulants are now utilized in various settings, including atrial fibrillation, venous thromboembolism, post-surgical care, and prevention.
- Aging population: An increasing number of patients are developing conditions like atrial fibrillation that necessitate anticoagulation.
- Earlier detection: Improved screening tools and wearable technology are helping to identify at-risk patients sooner.
- Stronger guidelines: Current clinical recommendations advocate for broader and earlier use in suitable patients.
- Greater physician confidence: Long-term data and real-world experience have made prescribing these medications more routine.
In summary, anticoagulants have transitioned from complex, high-maintenance therapies to standard, widely used treatments in modern healthcare.”
Stay updated with Hemostasis Today.
-
Apr 23, 2026, 14:52Anticoagulation Management and Outcomes in Patients with Cancer-Associated Small Venous Thromboembolism – JTH
-
Apr 23, 2026, 14:42Salih Ehsan: Bradykinin-Mediated Transfusion Reactions in Patients on ACE Inhibitors
-
Apr 23, 2026, 14:39Mona Alfaraj: Don’t Miss the Chance to Be Part of the 2nd International Hematology and Hemostasis Conference
-
Apr 23, 2026, 14:11Emerging Contributions to Hemostasis from Recipients of the Christine Lee Young Researcher Awards – WFH
-
Apr 23, 2026, 13:52Joffrey Feriel: A Revised ISTH Definition of Disseminated Intravascular Coagulation
-
Apr 23, 2026, 13:39Mazou Ngou Temgoua: Cancer and VTE – Toward Truly Personalized Anticoagulation
-
Apr 23, 2026, 13:35Jecko Thachil: Risk Assessment and Clinical Management of Nephrotic Syndrome–Associated Thrombosis
-
Apr 23, 2026, 12:18Mona Ranade: A Contemporary Framework for Managing Right Heart Thrombus in PE
-
Apr 23, 2026, 11:59Strengthening Hemophilia Care Through Collaboration and Commitment in India at IHC X 2026 – Hemophilia Federation India